Skip to main content
Livermore
Livermore
ZHEN

UBS Group AG

SEC CIK
0001610520
Latest filing
Aug 13, 2026

OBIO holding history

Orchestra BioMed Holdings, Inc. in every 13F filed by UBS Group AG, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

OBIO overviewAll 13F holders of OBIOFull Q2 2026 holdings

Shares (Q2 2026)
325,773
Value
$1.41M
% of portfolio
<0.1%
Quarters held
19
Since Q1 2021
Holdings of OBIO by UBS Group AG, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 2026325,773$1.41M<0.1%+275,463+547.5%AddedHolders
Q1 202650,310$213.8K<0.1%+38,921+341.7%AddedHolders
Q4 202511,389$47.3K<0.1%+7,574+198.5%AddedHolders
Q3 20253,815$9.46K<0.1%−22,324−85.4%ReducedHolders
Q2 202526,139$70.1K<0.1%+8,869+51.4%AddedHolders
Q1 202517,270$73.9K<0.1%−6,795−28.2%ReducedHolders
Q4 202424,065$96.3K<0.1%+12,583+109.6%AddedHolders
Q3 202411,482$59.0K<0.1%+4,328+60.5%AddedHolders
Q2 20247,154$58.3K<0.1%−7,572−51.4%ReducedHolders
Q1 202414,726$77.6K<0.1%+1,294+9.6%AddedHolders
Q4 202313,432$122.6K<0.1%+5,938+79.2%AddedHolders
Q3 20237,494$65.3K<0.1%+79+1.1%AddedHolders
Q2 20237,415$51.9K<0.1%+7,415NewHolders
Q4 20220$00.0%−2,824−100.0%Sold outHolders
Q3 20222,824$28.0K<0.1%+2,327+468.2%AddedHolders
Q2 2022497$5.00K<0.1%+440+771.9%AddedHolders
Q1 202257$1.00K<0.1%+57NewHolders
Q4 20210$00.0%−537−100.0%Sold outHolders
Q3 2021537$5.00K<0.1%−590−52.4%ReducedHolders
Q2 20211,127$12.0K<0.1%+249+28.4%AddedHolders
Q1 2021878$10.0K<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.